New hope for Hard-to-Treat cancers: first human trial launches
Disease control
Recruiting now
This early-phase study tests a new oral drug, DPTX3186, in 40 adults with advanced solid tumors (like colorectal, lung, or breast cancer) that have a specific genetic change (Wnt pathway) and no remaining standard treatments. The main goals are to check safety and how the drug mo…
Phase: PHASE1 • Sponsor: Dewpoint Therapeutics • Aim: Disease control
Last updated Jun 02, 2026 11:40 UTC